News Releases

News & Events

News Releases

Synteract Moves to New Headquarters in Carlsbad, San Diego County, California

SAN DIEGO & RALEIGH, NC – Oct. 4, 2017Synteract, a leading full-service global contract research organization (CRO), has recently moved to its expansive new facility in Carlsbad, California. The approximately 38,000 square feet of space at 5909 Sea Otter Place has been designed with an open concept to foster collaboration and creates a dynamic team environment, right in line with the company’s innovative business philosophy. Headquartered in San Diego County, with additional offices in the Research Triangle Park (RTP) area of North Carolina as well as 10 additional offices in Western, Central, and Eastern Europe, Synteract sits in six of the top 10 biotech centers in the world and supports clients in conducting clinical trials worldwide.

Synteract has seen some exciting changes in the recent months. Steve Powell joined Synteract in July as CEO to further advance the CRO’s highly responsive service offerings for its innovative customers. Recently, CEO Powell and Vice President for Strategic Development Etienne Drouet were named to the 2017 PharmaVOICE 100, a list of the 100 most inspiring people in the life sciences industry, which annually identifies industry thought leaders and innovators that have the biggest impact on the field. 

About Synteract
With 800 staff members across 21 countries, Synteract is an international full-service contract research organization with a successful three-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Synteract has conducted Phase I-IV studies on six continents and in more than 60 countries, offering broad therapeutic expertise, with notable depth in oncology, immunotherapy, CNS, and infectious disease, among other indications. With its “Shared Work – Shared Vision” philosophy, Synteract provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data to help bring tomorrow’s treatments to patients.

# # #
Beth Walsh   


Contact Synteract

Tell us how to stay in touch with you: